Literature DB >> 35696013

The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Semer Maksoud1.   

Abstract

Gliomas are the most frequent type of tumor in the central nervous system, which exhibit properties that make their treatment difficult, such as cellular infiltration, heterogeneity, and the presence of stem-like cells responsible for tumor recurrence. The response of this type of tumor to chemoradiotherapy is poor, possibly due to a higher repair activity of the genetic material, among other causes. The DNA double-strand breaks are an important type of lesion to the genetic material, which have the potential to trigger processes of cell death or cause gene aberrations that could promote tumorigenesis. This review describes how the different cellular elements regulate the formation of DNA double-strand breaks and their repair in gliomas, discussing the therapeutic potential of the induction of this type of lesion and the suppression of its repair as a control mechanism of brain tumorigenesis.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Keywords:  DNA; Double-strand break; Glioma; HR; NHEJ; Temozolomide

Mesh:

Substances:

Year:  2022        PMID: 35696013     DOI: 10.1007/s12035-022-02915-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  396 in total

1.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

Review 2.  Progenitor cells and glioma formation.

Authors:  E C Holland
Journal:  Curr Opin Neurol       Date:  2001-12       Impact factor: 5.710

3.  Addressing diffuse glioma as a systemic brain disease with single-cell analysis.

Authors:  Felix Sahm; David Capper; Astrid Jeibmann; Antje Habel; Werner Paulus; Dirk Troost; Andreas von Deimling
Journal:  Arch Neurol       Date:  2011-12-12

4.  Modulation of radiation-induced strand break repair by cisplatin in mammalian cells.

Authors:  J A Dolling; D R Boreham; D L Brown; R E Mitchel; G P Raaphorst
Journal:  Int J Radiat Biol       Date:  1998-07       Impact factor: 2.694

5.  Adaptive responses in human glioma cells assessed by clonogenic survival and DNA strand break analysis.

Authors:  D M Smith; G P Raaphorst
Journal:  Int J Radiat Biol       Date:  2003-05       Impact factor: 2.694

6.  Conditional probability of long-term survival in glioblastoma: a population-based analysis.

Authors:  Derek R Johnson; Daniel J Ma; Jan C Buckner; Julie E Hammack
Journal:  Cancer       Date:  2012-05-08       Impact factor: 6.860

Review 7.  Advances in local therapy for glioblastoma - taking the fight to the tumour.

Authors:  Thomas S van Solinge; Lisa Nieland; E Antonio Chiocca; Marike L D Broekman
Journal:  Nat Rev Neurol       Date:  2022-03-11       Impact factor: 44.711

8.  MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.

Authors:  Tianzhi Huang; Chung Kwon Kim; Angel A Alvarez; Rajendra P Pangeni; Xuechao Wan; Xiao Song; Taiping Shi; Yongyong Yang; Namratha Sastry; Craig M Horbinski; Songjian Lu; Roger Stupp; John A Kessler; Ryo Nishikawa; Ichiro Nakano; Erik P Sulman; Xinghua Lu; Charles David James; Xiao-Ming Yin; Bo Hu; Shi-Yuan Cheng
Journal:  Cancer Cell       Date:  2017-12-11       Impact factor: 31.743

9.  Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.

Authors:  Bowen Xie; Lu Zhang; Wenfeng Hu; Ming Fan; Nian Jiang; Yumei Duan; Di Jing; Wenwu Xiao; Ruben C Fragoso; Kit S Lam; Lun-Quan Sun; Jian Jian Li
Journal:  Redox Biol       Date:  2019-04-09       Impact factor: 11.799

10.  Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

Authors:  Wei Wu; Jessica L Klockow; Michael Zhang; Famyrah Lafortune; Edwin Chang; Linchun Jin; Yang Wu; Heike E Daldrup-Link
Journal:  Pharmacol Res       Date:  2021-07-21       Impact factor: 10.334

View more
  1 in total

1.  Requirements for MRN endonuclease processing of topoisomerase II-mediated DNA damage in mammalian cells.

Authors:  Yilun Sun; Eroica Soans; Margarita Mishina; Elena Petricci; Yves Pommier; Karin C Nitiss; John L Nitiss
Journal:  Front Mol Biosci       Date:  2022-09-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.